Overview

Efficacy and Safety of Grass Pollen Sublingual Immunotherapy

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The study is assessing efficacy and safety of three different dosage regimens of grass pollen sublingual immunotherapy in adult patients suffering from grass pollen related rhinoconjunctivitis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Artu Biologicals